High Quality, Automated Oncology ‘Omics Reporting with Velsera’s Knowledgebase
Speaker: Will Moller, Velsera’s Director of Product Management
Velsera’s end-to-end clinical NGS support across the wet and dry lab culminates in its clinical reporting automation, which identifies clinically important biomarkers in a patient specimen and conveys the medical meaning of those biomarkers to the reporting physician. In this session, we highlight how Velsera’s Knowledgebase powers these insights based on our expert curation of current medical knowledge and clinical trial opportunities. We also overview how Velsera's platform focuses your effort on the key alterations and highest value therapeutic, prognostic, and diagnostic associations for reporting.